hydrochlorothiazide + chlorthalidone + furosemide + torsemide + bumetanide

This is a hypothetical combination of five diuretic medications—hydrochlorothiazide, chlorthalidone, furosemide, torsemide, and bumetanide. All five are used individually to manage hypertension and fluid overload by promoting renal excretion of sodium and water but belong to two different classes of diuretics. Hydrochlorothiazide and chlorthalidone are thiazide or thiazide-like diuretics that act primarily on the distal convoluted tubule in the nephron to inhibit sodium-chloride symporters. Furosemide, torsemide, and bumetanide are loop diuretics that act on the Na-K-2Cl symporter in the thick ascending limb of Henle’s loop. These drugs reduce blood pressure and treat edema associated with heart failure, liver cirrhosis, or kidney disease by increasing urine output. Combining multiple agents from these classes is not standard clinical practice due to overlapping mechanisms and increased risk for adverse effects such as electrolyte disturbances (e.g., hypokalemia), dehydration, renal dysfunction, or hypotension[5][6][8].